- Introduced
- In committeeEnergy and Commerce
- Passed the House (not yet)
- Passed the Senate (not yet)
- Law (not yet)
What it would change
About this text
Text: Introduced The text as a member of Congress first filed it. Most bills never get further than this., (the only version so far)
This bill would change existing law, but we couldn't automatically match its changes to the Code.
Its own words follow, each change we couldn't place marked where it stands.
1 change we couldn't place in the Code
- title xvii of the public health service act (42 U.S.C. 300u et seq.) In the bill’s text
Sec. 1. Establishment of drug adherence guidelines Title XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by inserting after section 1711 (42 U.S.C. 300u–16) the following:
1712. Establishment of drug adherence guidelines
(a) In general.— The Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.
(b) Contents.— In establishing the guidelines under subsection (a), the Secretary shall—
(1) incorporate artificial intelligence and machine learning technologies; and
(2) to the maximum extent practicable, promote the use of generic and biosimilar drugs.
(c) Definitions.— In this section:
(1) Medicare part b drug.— The term “Medicare part B drug” means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.).
(2) Medicare part d drug.— The term “Medicare part D drug” means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e))).
.
We couldn't place this change in the Code: we can't yet make this kind of change, such as adding a whole new section.